MET · 8-K · 20260805PR000048
Operating Income and Margins
METLIFE INC · 2026-08-05 · Importance 41 · Surprise 22 · In source text
Adjusted earnings rose 15% to $1.573 billion on a reported basis and 14% on a constant-currency basis, driven by favorable underwriting and broad-based volume growth. Adjusted return on equity increased to 17.0% from 14.6%, reaching the top of the company’s stated range for the second consecutive quarter. The direct expense ratio excluding notable direct-expense items and PRT increased to 12.1% from 11.7%, although MetLife said it remained on track for its annual target. GAAP total expenses increased to $18.119 billion from $16.360 billion, including higher policyholder benefits, interest credited to policyholder accounts and other expenses.
Key facts
- Net income (loss) available to MetLife, Inc.'s common shareholders reconciliation: net income available $705 million; weighted average diluted shares 646.9; adjusted earnings available $1,573 million source
- Adjusted earnings for 2Q 2026: $1,573 million source
- Net income for 2Q 2026: $705 million source
- Adjusted return on equity (Adjusted ROE) for 2Q 2026: 17.0% source
- Net income per share for 2Q 2026: $1.09 source
- Adjusted earnings per share for 2Q 2026: $2.43 source
- Reported ROE for 2Q 2026: 11.5% source
- Total notable items for 2Q 2026: $0 source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | realized | — | Net income (loss) available to MetLife, Inc.'s common shareholders reconciliation: net income available $705 million; weighted average… |
| net_income | positive | realized | — | Adjusted earnings for 2Q 2026: $1,573 million |